(i) an assessment of progress toward prevention, treatment, and care targets;
(ii) an assessment of the effects on health systems, including on the financing and management of health systems and the quality of service delivery and staffing;
(iii) an assessment of efforts to address gender-specific aspects of HIV/AIDS, including gender-related constraints to accessing services and addressing underlying social and economic vulnerabilities of women and men;
(iv) an evaluation of the impact of treatment and care programs on 5-year survival rates, drug adherence, and the emergence of drug resistance;
(v) an evaluation of the impact of prevention programs on HIV incidence in relevant population groups;
(vi) an evaluation of the impact on child health and welfare of interventions authorized under the Act on behalf of orphans and vulnerable children;
(vii) an evaluation of the impact of programs and activities authorized in the Act on child mortality; and
(viii) recommendations for improving the HIV/AIDS programs implemented under the U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
Sponsor: U.S. Department of State.